William Blair Investment Management LLC Decreases Stock Holdings in Cencora, Inc. $COR

William Blair Investment Management LLC reduced its holdings in shares of Cencora, Inc. (NYSE:COR) by 30.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 24,356 shares of the company’s stock after selling 10,549 shares during the period. William Blair Investment Management LLC’s holdings in Cencora were worth $8,226,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of COR. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Cencora by 13.0% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,270 shares of the company’s stock valued at $15,086,000 after purchasing an additional 5,543 shares during the period. AustralianSuper Pty Ltd purchased a new position in shares of Cencora in the third quarter valued at $26,191,000. Mediolanum International Funds Ltd boosted its stake in shares of Cencora by 133.0% in the third quarter. Mediolanum International Funds Ltd now owns 56,293 shares of the company’s stock valued at $17,342,000 after purchasing an additional 32,138 shares during the period. Chilton Investment Co. Inc. purchased a new position in shares of Cencora in the third quarter valued at $459,000. Finally, Advisors Asset Management Inc. boosted its stake in shares of Cencora by 40.3% in the third quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock valued at $5,407,000 after purchasing an additional 4,973 shares during the period. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on COR. UBS Group upped their target price on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday. William Blair initiated coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Robert W. Baird cut their price target on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a report on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 price target on shares of Cencora in a report on Friday, May 8th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $380.25.

Cencora Trading Down 1.1%

COR opened at $271.84 on Wednesday. The stock has a market capitalization of $52.89 billion, a PE ratio of 20.85, a P/E/G ratio of 1.27 and a beta of 0.64. The firm’s fifty day moving average price is $302.59 and its 200 day moving average price is $335.67. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the company earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th. Cencora’s dividend payout ratio is 18.40%.

Cencora announced that its Board of Directors has authorized a share buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.